Join Communities

Search Notes Gallery

Home / AKTU 2ND YEAR NOTES / Microbiology and Immunology Unit 3 Notes – Immune System, Antigens and Antibodies

Microbiology and Immunology Unit 3 Notes – Immune System, Antigens and Antibodies

Mr. Verma
Nov 17, 2026 • 34 min read
Microbiology and Immunology Unit 3 Notes – Immune System, Antigens and Antibodies Source: NotesGallery

Course: AKTU B.Tech 2nd Year | Semester III

Course Code: BBT302

Branch: Biotechnology (BT)

Unit III Overview

Study innate and adaptive immunity, immune cells and lymphoid organs, B/T-cell development and activation, antigen recognition and antibody functions. Labelled diagrams, genuine micrographs and worked questions connect each structure with its immune role.

Topics Covered

Syllabus area Pages
Innate and adaptive immunity 2-4
Immune cells and molecules 4-6
Primary and secondary lymphoid organs 6-8
B/T maturation and activation 8-11
Antigens, epitopes and adjuvants 11-12
Antibodies and their classes 12-15
Monoclonal antibodies 15-17
Solved problems and revision 17-20

Learning Outcomes

  • Compare innate, adaptive, humoral and cellular responses.
  • Relate immune cells and lymphoid organs to their roles.
  • Distinguish lymphocyte maturation from activation.
  • Explain antigens, epitopes, haptens and adjuvants.
  • Identify antibody classes and the monoclonal-antibody principle.

Included in These Notes

37 explained sections; 24 labelled illustrations and plots; 10 actual photographs; 10 solved problems; comparison tables; answered revision questions and a formula sheet.

Study Approach

Track the response. Identify the barrier, tissue, organ and cells involved.

Separate the stages. Maturation prepares a repertoire; activation generates appropriate effectors and memory.

Link structure to function. Connect receptor recognition, antibody binding and recruited effector mechanisms.

Revise with comparisons. Use the diagrams, class tables and answered questions to explain each distinction.

Key distinctions: maturation is not activation; an antigen is not necessarily a strong immunogen; antibody binding is not the same as recruited effector action. Name the cell, molecule and process.

1. Immune-system overview: recognition, response and memory

The immune system is a coordinated network of barriers, cells, tissues and soluble molecules that protects the body while limiting damage to its own structures. Recognition must lead to an appropriate response, followed by regulation and resolution. An effective response is not simply the strongest possible inflammation.

Innate immunity provides rapid, broadly available recognition and defence. Adaptive immunity uses diverse antigen-specific B- and T-cell receptors, clonal expansion and memory. The systems cooperate: innate sensing helps initiate adaptive responses, while antibodies can improve innate effector activity. Unit III connects these mechanisms with lymphoid organs, lymphocyte maturation and activation, antigens, antibody classes and monoclonal antibodies.

Immune-system overview: recognition, response and memory.

Figure explanation: A barrier surface, innate effector and adaptive lymphocyte are connected through signals, antigen handling and recruited effectors. Immune defence is coordinated across cells and soluble molecules.

2. Innate and adaptive immunity: a functional comparison

Innate receptors recognise recurring microbial patterns or signals of tissue damage. Relevant responses include barriers, phagocytosis, inflammatory signalling, natural-killer activity and soluble defence proteins. These receptors are germline-encoded rather than individually rearranged to create a unique receptor in each lymphocyte clone.

Adaptive receptors arise through gene rearrangement, creating a large repertoire before a particular encounter. Antigen selects suitable clones, which proliferate and differentiate. Memory can accelerate a later response. The classical comparison of innate “no specific memory” versus adaptive memory is useful, but trained innate responses exist; it is inaccurate to claim that innate cells can never be functionally altered by prior exposure. Neither arm operates in isolation.

Feature Innate immunity Adaptive immunity
Recognition Patterns and damage-related signals Clone-specific antigen receptors
Typical initial timing Rapid availability Expansion takes time in a first response
Major components Barriers, phagocytes, NK cells, soluble proteins B cells, T cells and antibodies
Receptor origin Germline-encoded recognition systems Rearranged antigen-receptor genes
Classical memory No conventional B/T clonal memory Antigen-specific memory populations

3. Physical, chemical and biological barriers

Intact skin and epithelial surfaces form a physical obstacle. Mucus traps material, ciliary movement supports clearance, and fluid flow helps remove microbes. Tight epithelial organisation matters as much as the mere presence of a surface layer. A damaged barrier can change access without automatically producing infection.

Chemical defences include acidic environments, lysozyme and antimicrobial peptides at appropriate sites. Resident microbiota can compete for resources and influence host responses, although some members cause disease when context changes. Barrier protection is site-dependent: skin, respiratory mucosa and intestine have different structures. Remember: exclusion, trapping, movement and chemical inhibition are complementary mechanisms, not interchangeable labels.

Physical, chemical and biological barriers.

Figure explanation: Mucus traps material above an epithelial layer, while cilia support clearance. Epithelial continuity and local antimicrobial factors contribute additional defence.

4. Adaptive specificity, diversity, selection and memory

A lymphocyte clone has a receptor specificity shared by its descendants. Antigen recognition selects suitable pre-existing clones; antigen does not instruct a cell to invent exactly the needed receptor sequence. Activation drives expansion and differentiation into effector and memory populations under appropriate signals.

Diversity prepares the system for many targets. Specificity is selective binding, not an absolute promise that cross-reactivity never occurs. Tolerance limits damaging self-reactivity, while contraction removes many effectors after the response. Some plasma cells and memory cells persist. A secondary response depends on the antigen, prior exposure and host state; it is not automatically stronger for every possible antigen or every individual.

Active versus passive: active immunity follows the recipient’s own response, for example after infection or vaccination. Passive immunity supplies preformed antibody, such as maternal IgG or administered immunoglobulin. It can act promptly but does not itself establish the recipient’s antigen-specific memory.

5. Humoral and cell-mediated immune responses

Humoral adaptive immunity centres on antibodies produced by differentiated B cells. Antibodies can bind extracellular microbes or toxins and recruit other effector systems. The presence of cells in the process does not make it “cell-mediated” in the conventional classification; all antibody production ultimately depends on cells.

Cell-mediated adaptive immunity centres on T-cell functions: helper subsets coordinate responses, cytotoxic T cells can remove infected or altered host cells, and regulatory T cells limit inappropriate activity. Helper T cells also support many antibody responses, so the two arms overlap functionally. Natural-killer cells are innate cytotoxic lymphocytes and should not be relabelled antigen-specific cytotoxic T cells simply because both kill targets.

Humoral and cell-mediated immune responses.

Figure explanation: The B/plasma-cell lineage produces antibodies acting on targets; the T-cell lineage recognises suitable targets and coordinates or carries out cellular responses. The two arms remain connected.

6. Immune cells: origins, lineages and identification

Immune blood cells arise through haematopoiesis from stem-cell populations in bone marrow. A broad teaching scheme separates myeloid-associated cells, including granulocytes and monocytes, from lymphoid-associated B cells, T cells and natural-killer cells. Dendritic-cell and tissue-resident populations have more complex developmental histories than one rigid two-branch chart suggests.

A stained blood film shows morphology: nuclei, cytoplasm and granules help distinguish broad cell types. It does not reliably distinguish all B-cell, T-cell and activation states without additional markers or functional information. Red blood cells are not conventional leukocytes, and platelets are cell fragments with important haemostatic and inflammatory interactions. The accompanying photographs are genuine observations, not universal identity tests.

Immune cells: origins, lineages and identification.

Figure explanation: The simplified stem-cell map branches into myeloid-associated and lymphoid-associated populations. Granulocytes, monocytes, B cells, T cells and NK cells illustrate major groups; development is more complex than this outline.

Blood-smear overview: eosinophil, basophil and a small lymphocyte among erythrocytes.

Figure explanation: The labelled blood smear compares a segmented eosinophil, a granular basophil and a small lymphocyte among erythrocytes. Staining and morphology support recognition of broad cell types.

7. Neutrophils, phagocytosis and early defence

Neutrophils are prominent rapidly recruited phagocytes in many acute responses. Their segmented nuclei and cytoplasmic granules aid morphological recognition. Recruitment to tissues involves adhesion, migration through vessel walls and movement along appropriate chemical gradients. In ordinary inflammatory recruitment, postcapillary venules are important exit sites.

Phagocytosis proceeds through recognition/attachment, engulfment into a phagosome, interaction with lysosomal compartments and antimicrobial processing. Antibody or complement coating can enhance uptake: this is opsonisation. Intracellular killing and removal of debris are related but distinct from engulfment alone. A static image of a cell beside a bacterium does not by itself prove completed killing. The labelled sequence explains the stages separately.

Neutrophils, phagocytosis and early defence.

Figure explanation: The sequence is attachment, engulfment into a phagosome and intracellular processing. Engulfment alone does not prove that killing has been completed.

Blood smear: the arrowhead marks a lymphocyte; the lower cell is a lobed neutrophil.

Figure explanation: The arrowhead indicates a lymphocyte; the lower lobed cell is a neutrophil. Compare their nuclear and cytoplasmic appearance without assigning lymphocyte subtype from morphology alone.

Colourised SEM: a neutrophil interacting with Klebsiella bacteria.

Figure explanation: The colourised SEM shows a neutrophil interacting with Klebsiella bacteria. It illustrates a cell-bacterium encounter rather than measuring the success of intracellular killing.

8. Monocytes, macrophages and dendritic cells

Monocytes circulate in blood; some enter tissues and contribute to macrophage populations. Many tissue-resident macrophages also have developmental origins and maintenance patterns that cannot be reduced to continual replacement from blood monocytes. Macrophages ingest material, remove debris and release signals that shape local responses.

Dendritic cells are especially important in initiating many responses of naïve T cells. They connect tissue antigen encounter with presentation and appropriate co-stimulation in lymphoid tissue. Macrophages and B cells can also present antigen in relevant settings. Antigen-presenting function is not the same as secreting antibodies. The pathological micrograph is explicitly labelled: it illustrates intracellular organisms in a macrophage, not a normal reference appearance for every tissue.

Monocytes, macrophages and dendritic cells.

Figure explanation: An antigen-presenting cell supplies peptide–MHC recognition and co-stimulation to a naïve T cell. Dendritic cells are important for priming many naïve T-cell responses.

Monocyte morphology in a stained peripheral-blood film.

Figure explanation: The stained blood film illustrates monocyte morphology. Cell shape and nuclear appearance are descriptive observations, not a direct assay of antigen presentation.

TEM of an infected mouse specimen: a macrophage containing intracellular organisms; not normal tissue.

Figure explanation: This TEM is an infected mouse specimen showing a macrophage containing intracellular organisms. It illustrates pathological material rather than normal macrophage anatomy.

9. Eosinophils, basophils, mast cells and NK cells

Eosinophils contain conspicuous granules and participate in selected parasite-related and inflammatory responses. Basophils circulate; mast cells reside mainly in tissues. Basophils and mast cells have overlapping mediator functions, including IgE-associated activation, but are not simply the same cell in different photographs.

Natural-killer cells integrate activating and inhibitory signals to identify appropriate targets, including some stressed or infected cells. They can also participate in antibody-dependent cellular cytotoxicity through Fc-receptor recognition of coated targets. They do not use a rearranged antigen-specific T-cell receptor. Cell function depends on receptor context and signals; granules or a rounded appearance alone do not establish a complete functional diagnosis.

Eosinophil and surrounding red blood cells in a blood smear.

Figure explanation: The arrowhead marks an eosinophil among red blood cells. Its appearance can be compared with the other granulocyte photographs.

Basophil with conspicuous cytoplasmic granules in a blood smear.

Figure explanation: The basophil has conspicuous cytoplasmic granules. These visible structures do not directly demonstrate release of a particular mediator.

10. B and T lymphocytes: recognition is different

B-cell receptors are membrane immunoglobulins associated with signalling proteins. A mature naïve B cell commonly displays IgM and IgD with the same underlying antigen-binding specificity. B cells can recognise accessible native antigen, including conformational features of an intact molecule.

Conventional αβ T-cell receptors recognise peptide-MHC complexes rather than simply binding freely dissolved intact antigen as an antibody does. CD4 and CD8 act as co-receptors in their usual MHC class II and class I relationships. Not every lymphocyte fits this conventional model; specialised populations exist. For this unit, distinguish the major BCR and TCR models while reserving detailed processing pathways and MHC organisation for Unit IV.

A lymphocyte in a blood smear; morphology alone does not establish B- or T-cell identity.

Figure explanation: The arrowhead identifies a lymphocyte. A conventional blood-smear image cannot by itself distinguish B-cell from T-cell identity.

11. Molecules of immunity: receptors, signals and effectors

Immune molecules include recognition receptors, antibodies, cytokines, chemokines, complement proteins, adhesion molecules and antimicrobial substances. Cytokines coordinate cell behaviour; chemokines guide migration. A molecule’s effect depends on receptor expression, concentration and tissue context, rather than one universal action on every cell.

Antibodies provide antigen-specific recognition and can recruit complement or Fc-receptor-bearing cells. Complement contributes to opsonisation, inflammation and, for suitable targets, membrane injury. It is not synonymous with an antibody. Adhesion and co-stimulatory molecules support productive cell interactions. These are functional connections only; detailed complement pathways and cytokine networks belong to the next unit. Memory: recognise, communicate, recruit and execute are distinct molecular roles.

12. Primary and secondary lymphoid organs

Primary lymphoid organs support development of a diverse, appropriately selected lymphocyte repertoire. In humans, bone marrow is the major site of early B-cell development and the source of T-cell precursors; the thymus supports T-cell maturation. Primary does not mean “the first organ to become infected”.

Secondary lymphoid organs and tissues organise encounters between mature lymphocytes, antigen and other cells. They include lymph nodes, spleen and mucosa-associated lymphoid tissue. Lymph nodes receive tissue-derived lymph; the spleen surveys blood. Lymphocyte recirculation connects these sites. “Mature” does not mean “already activated”: a naïve mature lymphocyte is equipped to respond but has not yet undergone its relevant antigen-driven activation.

Primary and secondary lymphoid organs.

Figure explanation: The body map locates thymus, bone marrow, spleen and lymph nodes. Marrow and thymus support repertoire development; secondary organs organise antigen encounter.

Category Main human examples Principal role
Primary Bone marrow and thymus Development and selection of lymphocytes
Secondary Lymph nodes, spleen and MALT Organised antigen encounter and adaptive activation
Bone marrow nuance Also contains antibody-secreting cells An organ can support more than one immune function

13. Bone marrow and early lymphocyte development

Bone-marrow niches provide support for haematopoiesis and B-lineage development. Rearrangement of antigen-receptor gene segments creates diversity before the cell encounters the particular foreign antigen that may later activate it. Functional receptor assembly and survival signals shape which developing cells persist.

Self-reactive immature B cells can undergo receptor editing, deletion or functional inactivation, depending on context. Early B-cell development in marrow is followed by further peripheral maturation, notably through transitional stages associated with the spleen. Bone marrow also supports some long-lived plasma cells after immune responses. Distinguish the developmental role of the marrow from its later role as a home for differentiated antibody-secreting cells.

14. Thymus: cortex, medulla and T-cell education

The thymus has lobules with a more densely cellular cortex and a relatively lighter medulla. Developing thymocytes interact with stromal and antigen-presenting cells. Cortical and medullary environments contribute differently to maturation and selection; the organ is not simply a store of fully activated killer cells.

Positive selection supports cells able to interact appropriately with self-MHC. Strongly self-reactive cells can be removed or diverted into regulatory lineages in suitable settings. Cells that fail necessary survival tests do not simply become harmless mature T cells automatically. The thymus is most active earlier in life and undergoes involution, but this does not mean all T-cell immunity abruptly disappears in adults.

Thymus: cortex, medulla and T-cell education.

Figure explanation: The thymic lobule distinguishes cortex from medulla. T-cell selection depends on organised cellular and stromal interactions rather than simply passage through an empty compartment.

15. Lymph nodes: tissue surveillance and organised zones

Lymph enters a node through afferent vessels, passes through sinus spaces and leaves through efferent drainage at the hilum. The cortex contains B-cell follicles; the paracortex is rich in T cells; medullary regions include cords and sinuses. High endothelial venules support entry of many circulating lymphocytes.

Antigen-bearing cells, lymph-borne material and recirculating lymphocytes meet in an organised environment. Germinal centres can develop in responding follicles. A node filters lymph, not the body’s main circulating blood volume. The archived tissue photograph shows a disease-associated specimen and must not be mistaken for a normal architecture atlas. Use the labelled diagram for the basic regional arrangement.

Lymph nodes: tissue surveillance and organised zones.

Figure explanation: Afferent lymph enters the node and efferent lymph leaves at the hilum. B-cell follicles, the T-cell paracortex and medullary regions organise different aspects of the response.

Archived typhoid lymph-node histology with macrophages and lymphocytes; pathological tissue, not normal anatomy.

Figure explanation: This archived typhoid lymph-node section contains macrophages and lymphocytes in pathological tissue. It should not be used as an unqualified model of normal lymph-node architecture.

16. Spleen and mucosa-associated lymphoid tissue

The spleen surveys blood-borne material. White pulp contains lymphoid organisation, including T-cell-associated periarteriolar regions and B-cell follicles; red pulp participates in blood-cell filtering and clearance. A lymph node and spleen therefore share immune roles but differ in the fluid chiefly surveyed and their architecture.

Mucosa-associated lymphoid tissue (MALT) includes sites such as tonsillar tissue and intestinal lymphoid structures including Peyer’s patches. These support responses at exposed mucosal surfaces while balancing tolerance to harmless material. They are not primary maturation organs. Exam comparison: marrow/thymus develop the repertoire; nodes survey tissue drainage; spleen surveys blood; mucosal tissues organise local surface-related responses.

Spleen and mucosa-associated lymphoid tissue.

Figure explanation: The spleen model distinguishes white pulp from red pulp. Blood-borne antigen surveillance and blood-cell filtering are related but different functions.

17. B-cell maturation: from receptor assembly to naïve cell

B-lineage stages include pro-B, pre-B and immature B-cell development. Heavy-chain rearrangement and pre-B-receptor assessment precede successful complete surface immunoglobulin expression. Light-chain assembly contributes additional diversity. The diagram summarises developmental logic rather than a laboratory method for manufacturing cells.

An immature surface-IgM-bearing cell undergoes checks that reduce harmful self-reactivity. Transitional cells then complete important peripheral steps before joining the mature naïve population, commonly expressing IgM and IgD. Maturation creates immunocompetence; activation requires a suitable later encounter and signals. A plasma cell is an effector descendant after activation, not merely a synonym for an immature B cell.

B-cell maturation: from receptor assembly to naïve cell.

Figure explanation: Follow pro-B, pre-B, immature B and mature naïve B stages. Receptor assembly, checks on self-reactivity and peripheral maturation precede antigen-driven plasma-cell differentiation.

18. B-cell activation, plasma cells and memory

In a common T-dependent protein-antigen response, BCR recognition supports antigen uptake and presentation. Cognate helper-T-cell interactions, including co-stimulation and cytokine signals, promote expansion and differentiation. Linked recognition connects B-cell capture of antigen with T-cell recognition of a peptide derived from the associated material.

Activated B cells can form antibody-secreting plasma cells and memory populations. Germinal-centre reactions support selection, affinity maturation and class switching in appropriate responses. Some repetitive non-protein antigens can stimulate T-independent responses, often with different memory and class-switching characteristics. Not every antibody response follows exactly one pathway. Secreted antibody is an effector product; the BCR remains a cell-associated recognition system.

B-cell activation, plasma cells and memory.

Figure explanation: A selected B cell undergoes clonal expansion and generates plasma cells and memory B cells in a suitable antigen/help context. Plasma cells secrete antibody; memory cells support later responses.

19. T-cell maturation, positive and negative selection

T-cell precursors originate from marrow-associated haematopoiesis and mature in the thymus. TCR gene rearrangement produces diverse receptors. Developing cells pass through stages that can include CD4/CD8 double-positive expression before the conventional single-positive populations emerge.

Positive selection preserves useful self-MHC recognition; negative selection reduces dangerous self-reactivity. Selection is not a guarantee that every possible autoimmune response becomes impossible, so peripheral regulation remains important. Surviving conventional cells enter the circulation as mature naïve CD4 or CD8 cells. Maturation is developmental preparation; infection-associated activation and effector differentiation are later events. The cultured-cell micrograph is clearly labelled because viral particles on its surface do not illustrate normal thymic selection.

T-cell maturation, positive and negative selection.

Figure explanation: Thymic selection retains a useful self-MHC-recognising repertoire while limiting dangerous self-reactivity. Developmental selection differs from later activation by a foreign antigen.

Colourised SEM of a cultured lymphocyte with HIV particles on its surface; not a normal resting-cell image.

Figure explanation: The colourised SEM shows a cultured lymphocyte with HIV particles at its surface. It is an infection-associated image rather than a normal resting lymphocyte.

20. T-cell activation: antigen, co-stimulation and context

A conventional naïve T cell receives antigen-specific recognition through the TCR interacting with a suitable peptide-MHC complex, supported by co-receptors. Additional co-stimulation and cytokine context help determine whether and how the response develops. Recognition without an appropriate context need not produce productive effector expansion.

CD4 helper populations organise distinct response patterns; CD8 effector cells can recognise and remove suitable target cells. Regulatory T cells support control of unwanted responses. Activated clones expand and later contract, leaving memory populations in suitable responses. Do not draw a free antibody as the T-cell receptor or assume every cell displaying antigen can efficiently prime a naïve T cell. Detailed MHC processing is considered in Unit IV.

T-cell activation: antigen, co-stimulation and context.

Figure explanation: Antigen recognition and co-stimulation support activation of a naïve T cell. Cytokine context helps shape the resulting effector and memory populations.

21. Cooperation between humoral and cellular effectors

Helper T cells can support B-cell differentiation, while antibody-coated targets can be recognised by innate Fc-receptor-bearing cells. Antibody-mediated opsonisation makes capture easier; neutralisation blocks an important interaction; complement can contribute additional effector functions. These outcomes are not interchangeable ways of saying “the antibody eats the microbe”.

Cytotoxic T cells deliver regulated signals that can trigger target-cell apoptosis, rather than phagocytosing every target whole. Natural-killer cells use a different recognition framework despite some overlapping killing machinery. Regulation and removal of activated effectors limit collateral damage. A useful explanation names the recognition molecule, responding cell and effector action separately.

22. Antigens, immunogens and determinants of immunogenicity

An antigen is recognised by an antibody or antigen receptor in the relevant context. An immunogen can elicit an immune response. These definitions overlap but are not identical: a molecule can bind specifically without independently provoking a strong response. An epitope is the particular recognised part.

Immunogenicity depends on properties such as foreignness, molecular size, complexity and ability to be appropriately handled by the immune system. Dose, route, formulation, prior exposure and host genetics also matter. No single molecular-size threshold universally determines the result. Proteins commonly support strong, diverse responses, but other molecular categories can also be recognised and may require particular contexts or carrier associations.

Antigens, immunogens and determinants of immunogenicity.

Figure explanation: One antigen carries several distinct epitopes, labelled A, B and C. The whole recognised structure and an individual determinant are different levels of description.

23. Types of antigens and useful classifications

Classify antigens by the question being asked. Exogenous/endogenous describes origin relative to a cell; self/allo-/heterologous comparisons concern relationships to the host; T-dependent and T-independent describe the role of T-cell help in a particular B-cell response. These axes should not be merged into one inconsistent list.

Proteins, polysaccharides, lipids, nucleic acids and conjugated molecules differ in recognition and immunogenic context. Heterophile or cross-reacting determinants can be shared across apparently different sources. Superantigens can activate many T cells by an unusual interaction with MHC class II and selected TCR regions rather than conventional peptide-specific recognition. The concept explains a distinctive response pattern, not a general property of all antigens.

Classification axis Examples Meaning
Origin for a cell Exogenous and endogenous Outside-derived versus generated within
Relation to host Self, alloantigen, heterologous antigen Same individual, genetically different same species, or different source/species
B-cell response T-dependent and T-independent Whether suitable T-cell help is required in the response
Molecular form Protein, polysaccharide, conjugate Chemical nature; not a guarantee of identical immunogenicity

24. Epitopes, paratopes and cross-reactivity

An epitope is the antigenic determinant; the complementary binding region on an antibody is its paratope. A single large antigen can expose several epitopes, enabling responses from several clones. Linear epitopes depend mainly on a sequence segment, whereas conformational epitopes depend on the folded arrangement of residues.

Denaturation can disrupt a conformational determinant without destroying every linear determinant. Conventional T-cell recognition involves peptides presented by MHC, rather than the same direct intact-antigen interaction used by BCRs and antibodies. Similar molecular features can produce cross-reactivity. Therefore, one antibody specificity does not guarantee absolute binding to only one uniquely named molecule in every possible assay.

Epitopes, paratopes and cross-reactivity.

Figure explanation: A linear determinant follows an amino-acid sequence segment; a conformational determinant depends on folding. Denaturation can disrupt a fold-dependent binding surface.

25. Haptens and the carrier effect

A hapten is a small determinant that can bind an appropriate antibody but usually cannot independently induce the full relevant response. Coupling to a suitable carrier can provide an immunogenic context. Hapten-specific B cells may capture the linked material and obtain help involving carrier-derived peptides.

The resulting antibody can recognise free hapten even though the free hapten was a poor immunogen. Carrier and hapten therefore have different roles; the carrier does not merely make the hapten physically visible under a microscope. Penicillin-associated hapten-protein interactions provide a familiar conceptual example, but binding to a small molecule does not by itself establish that every exposed person develops an allergy. Keep antigenicity and immunogenicity separate.

Haptens and the carrier effect.

Figure explanation: The model links a small free hapten to a carrier. Recognition of a determinant and the capacity to elicit an immune response are separate properties.

26. Adjuvants: improving the context of recognition

An adjuvant is a component used with an antigen to enhance or shape the immune response in a particular formulation. It may promote innate signalling, recruitment, antigen handling or the context of presentation. Its action depends on its chemistry and formulation; a prolonged depot is not the sole universal explanation.

An adjuvant is not automatically the antigen being specifically targeted, and it does not rewrite the antigen’s sequence to create every desired antibody. Dose, route and biological setting affect performance. Alum-containing formulations are familiar examples, but this unit addresses principles rather than vaccine recipes or clinical selection. Compare: antigen supplies recognised determinants; carrier can provide linked immunogenic support; adjuvant improves the response context.

27. Antibody architecture: heavy and light chains

A conventional antibody monomer has two identical heavy chains and two identical light chains linked through disulfide bonds and other interactions. Variable domains of one heavy and one light chain together form each antigen-binding site. Constant heavy-chain regions define the antibody class and contribute effector interactions.

The flexible Y is an IgG-like model. Its hinge permits arm movement; IgM and IgE have an additional heavy-chain constant domain instead of the same classical hinge. Heavy chains γ, μ, α, δ and ε define IgG, IgM, IgA, IgD and IgE; usual light chains are κ or λ. Fab contains variable and constant domains; it is not identical to the variable region alone.

Antibody architecture: heavy and light chains.

Figure explanation: An IgG-like monomer contains two heavy and two light chains. The diagram labels variable domains, binding sites, hinge, Fc and disulfide-linked chain organisation.

28. Fab, Fc, binding strength and antibody functions

Fab regions contain the antigen-binding sites; Fc regions support class-dependent interactions with receptors, complement and transport systems. A conventional IgG-like monomer has two sites, but accessibility and geometry affect functional binding. Affinity describes one binding-site interaction; avidity describes the combined strength of multiple interactions.

Antibodies can neutralise, opsonise, cross-link material and recruit suitable effector systems. They are not phagocytes. In the standard IgG digestion comparison, papain produces two Fab fragments plus Fc, whereas pepsin yields a linked F(ab’)2 fragment with degraded Fc material. Class, subclass and context influence function; not every antibody activates complement or crosses a barrier equally.

Fab, Fc, binding strength and antibody functions.

Figure explanation: The two Fab regions support recognition, while Fc contributes class-dependent effector recruitment. Binding specificity and effector function are distinct properties.

29. IgG: distribution, subclasses and effector roles

IgG is the predominant immunoglobulin class in normal adult serum and is commonly important in secondary responses. It is monomeric. Different human IgG subclasses vary in properties such as Fc-receptor interaction and complement activation, so a single function should not be assigned equally to all subclasses.

IgG can neutralise, support opsonisation and recruit appropriate effectors. It is the main class transported across the placenta through receptor-mediated mechanisms, contributing passive protection to the fetus. Antibody transfer is not the same as transferring the mother’s memory B cells or making the infant actively immunised against every target. Serum abundance and antigen specificity are separate questions.

30. IgM: membrane monomer and secreted multimer

IgM is commonly the first secreted class in a primary antibody response. On a naïve B-cell surface it is a membrane monomer associated with signalling machinery. Secreted IgM is predominantly pentameric in its familiar J-chain-containing form, although other assemblies can occur.

A pentamer contains five antibody units and nominally ten antigen-binding sites. Geometry means that all sites are not necessarily engaged simultaneously with every antigen. Multivalency can generate strong avidity even when individual-site affinity is modest. IgM can efficiently initiate classical complement activation when appropriately bound. It is not the principal placentally transported antibody class, and the presence of antigen-specific IgM alone is not a universal stand-alone diagnosis.

IgM: membrane monomer and secreted multimer.

Figure explanation: The common secreted IgM model has five antibody units and a J chain, giving ten nominal binding sites. Membrane IgM is monomeric, and the drawing is not a statement that every secreted assembly is identical.

31. IgA: mucosal protection and secretory form

IgA supports defence at mucosal surfaces and in secretions. Serum IgA is mainly monomeric, while an important secretory form is dimeric and linked through a J chain. Epithelial transport involving the polymeric immunoglobulin receptor adds the secretory component to the released secretory IgA complex.

Secretory IgA can limit attachment and neutralise targets near exposed surfaces. It is an important antibody component of breast milk. The secretory component and J chain are different structures with different roles. Not every IgA molecule is a dimer, and milk-associated antibody transfer should not be confused with the placental IgG route. The diagram separates the two antibody units, linking chain and surrounding protective component.

IgA: mucosal protection and secretory form.

Figure explanation: The secretory IgA model includes two antibody units, a J chain and secretory component. Serum IgA is mainly monomeric; the depicted form emphasises mucosal secretion.

32. IgD and IgE: receptor and tissue-associated roles

IgD is present at low concentrations in serum and is commonly co-expressed with IgM on mature naïve B cells. These two surface classes can share antigen-binding specificity. Their presence is not evidence that the cell is secreting large quantities of both antibodies into blood.

IgE is usually scarce in serum but binds strongly to appropriate receptors on mast cells and basophils. Antigen-dependent cross-linking can trigger mediator release; IgE also contributes to selected parasite-associated responses. Eosinophils participate in related settings without being the source of antibody. IgE’s small serum concentration does not imply biological irrelevance. Detailed hypersensitivity classification and therapeutic applications are addressed later in the subject.

33. Comparison of all five antibody classes

Compare class using heavy chain, common molecular form, distribution and characteristic function. A class label does not identify the antigen recognised: two IgG antibodies can recognise different epitopes, while related antibodies of different classes can preserve the same underlying specificity.

Class switching changes heavy-chain constant-region use while retaining the rearranged antigen-binding variable sequence in the basic model. Affinity maturation instead selects improved antigen-binding variants. Neither process means that one finished extracellular antibody simply reshapes itself into every class. The table summarises common human teaching models, with physiological exceptions and subclass differences understood.

Class Heavy chain and common form Characteristic emphasis
IgG γ; monomer Serum/tissue defence; placental transport; subclass-dependent effectors
IgM μ; surface monomer, mainly secreted pentamer Early response; multivalent binding; classical complement
IgA α; serum monomer, common secretory dimer Mucosal and secretion-associated protection
IgD δ; monomer Naïve B-cell surface antigen receptor alongside IgM
IgE ε; monomer Mast-cell/basophil-associated responses and selected parasite defence

34. Primary, secondary and affinity-matured responses

A first suitable encounter commonly has a lag while selected clones expand. IgM often appears early, followed by class-switched antibodies when the response supports switching. Memory cells and some long-lived plasma cells contribute to a different response on re-exposure.

A secondary response to a suitable T-dependent antigen is often faster, larger and of higher average affinity, with substantial class-switched antibody.

These are general patterns, not a rule that IgM disappears or that every second exposure produces identical kinetics. Somatic hypermutation creates variable-region variants; selection and help favour appropriate clones. Response height, timing, specificity and affinity describe different properties and should not be read as one measurement.

Primary, secondary and affinity-matured responses.

Figure explanation: The illustrative antibody-response plot compares a primary response with a faster, larger secondary response after re-exposure. The axes show response signal and illustrative time rather than a universal schedule.

35. Monoclonal and polyclonal antibodies

A monoclonal antibody preparation derives from a defined clone or defined antibody-producing sequence and has a shared intended binding specificity. A polyclonal preparation contains antibodies from multiple clones, often recognising several epitopes of the same antigen. Polyclonal does not mean nonspecific or useless.

Monoclonal reagents support reproducibility and targeted recognition, but can miss altered or inaccessible epitopes and can still cross-react. Polyclonal mixtures may detect several determinants but can vary between preparations. A monoclonal antibody is not automatically a therapeutic product, and a single-epitope target description does not guarantee flawless performance in every assay. Select a reagent by the biological question and validated behaviour.

Monoclonal and polyclonal antibodies.

Figure explanation: A monoclonal preparation derives from one defined clone, whereas a polyclonal preparation contains products of several responding clones. Defined origin does not remove the need to check cross-reactivity.

Feature Monoclonal preparation Polyclonal preparation
Origin Defined clone or sequence Multiple responding clones
Intended recognition One defined specificity Several specificities may be present
Consistency Can be highly reproducible after validation Composition may vary between preparations
Important limitation Epitope alteration/accessibility; possible cross-reactivity Mixture complexity and variable background

36. Hybridoma principle: selection, screening and cloning

In the classical hybridoma concept, an antibody-producing B cell is combined with a suitable continuously growing myeloma partner. A hybrid can combine the antibody-producing capability with sustained growth. HAT refers to hypoxanthine, aminopterin and thymidine in the conventional selection framework.

With appropriately chosen parental cells, blocked de novo nucleotide synthesis and salvage-pathway requirements help exclude unfused myeloma cells, while ordinary unfused B cells have limited survival. Selection enriches suitable surviving hybrids; screening identifies the required antibody behaviour; cloning establishes a defined producer. Selection alone does not guarantee the desired specificity. The figure is a conceptual development sequence, not a production protocol or a substitute for quality control.

Hybridoma principle: selection, screening and cloning.

Figure explanation: The hybridoma principle combines a B-cell source with a myeloma partner. Selection, screening, cloning and validation are separate steps needed to obtain a defined useful preparation.

37. Monoclonal-antibody uses, modern formats and limitations

Monoclonal antibodies are used in research detection, cell identification, selected diagnostic systems and suitable therapeutic settings. Recombinant production and engineered formats extend beyond classical hybridomas. Chimeric, humanised and fully human descriptions concern antibody design or origin, not an automatic guarantee of safety, effectiveness or absence of cross-reactivity.

Useful quality questions include whether the reagent binds the intended target in the actual sample, distinguishes relevant alternatives, remains stable and has acceptable background. Binding an isolated purified protein does not prove equivalent performance on intact cells or denatured samples. Detailed immunoassay procedures belong to Unit IV; here the central point is the connection between clone-defined recognition, molecular format and demonstrated function.

WORKED QUESTIONS: IMMUNE MECHANISMS AND INTERPRETATION

The questions apply the stated teaching models. Identify the relevant cell, molecule and context before interpreting an observation; these examples are not stand-alone clinical diagnoses.

Worked problem 3.1: Innate cytotoxicity is not automatically T-cell immunity

Question: A cell kills an antibody-coated target by recognising the bound antibody through an Fc receptor. Must the responding cell be an antigen-specific cytotoxic T cell?

Step 1: The immediate recognised structure in the question is antibody Fc, not a peptide-MHC complex through a rearranged TCR.

Step 2: Natural-killer cells can contribute to antibody-dependent cellular cytotoxicity.

Step 3: The observation describes an effector interaction; it does not establish every marker on the responding cell.

Answer: No. An innate Fc-receptor-bearing effector such as an NK cell can perform this role.

Check: Humoral recognition and a cellular effector can cooperate; the usual categories are not isolated compartments.

Worked problem 3.2: Selecting the organ by the surveyed fluid

Question: Material drains from a peripheral tissue in lymph. Which secondary organ is the principal organised meeting site along that route: thymus, lymph node or spleen?

Step 1: The thymus supports T-cell development rather than routinely filtering peripheral tissue lymph.

Step 2: Lymph nodes receive afferent lymph from tissues.

Step 3: The spleen chiefly surveys blood-borne material.

Answer: A lymph node is the relevant organised site in the stated drainage route.

Check: Primary versus secondary describes immune function, not which organ receives the largest amount of any fluid.

Worked problem 3.3: Maturation versus activation

Question: A B cell has completed receptor development and peripheral maturation but has not encountered its relevant antigen in an activating context. Is it already a plasma cell?

Step 1: Development establishes a useful antigen-receptor repertoire and reduces harmful self-reactivity.

Step 2: A mature naïve B cell is prepared to respond but has not completed its antigen-driven effector differentiation.

Step 3: Plasma-cell formation follows appropriate activation and differentiation.

Answer: No. It is a mature naïve B cell, not automatically an antibody-secreting plasma cell.

Check: Surface IgM/IgD expression and high-rate secretion are different observations.

Worked problem 3.4: Antigen, hapten, carrier or adjuvant?

Question: A small determinant binds an existing antibody but elicits little response alone. Linking it to a protein supports a response, while another formulation component enhances innate activation. Identify the roles.

Step 1: Specific binding without strong independent immunogenicity is consistent with a hapten.

Step 2: The linked protein provides carrier-associated immunogenic support.

Step 3: The added context-enhancing component is an adjuvant rather than necessarily the specifically recognised determinant.

Answer: Small determinant: hapten; linked protein: carrier; context-enhancing component: adjuvant.

Check: Carrier and adjuvant are not synonyms, and antigenicity is not identical to immunogenicity.

Worked problem 3.5: The nominal number of binding sites

Question: Use the standard model of two sites per antibody monomer. Calculate nominal sites on one secreted IgM pentamer and one dimeric IgA.

Step 1: IgM pentamer: five monomeric units × two sites per unit=10 sites.

Step 2: Dimeric IgA: two monomeric units × two sites per unit=4 sites.

Step 3: These are structural nominal counts, not a promise of simultaneous binding to every antigen geometry.

Answer: 10 nominal sites for the IgM pentamer; 4 for dimeric IgA.

Check: Membrane IgM is monomeric, and serum IgA is mainly monomeric; the stated assembly matters.

Worked problem 3.6: Separating Fab from Fc function

Question: A reagent retains antigen binding after its Fc-dependent interactions are removed. Does this show that Fc was the original epitope-binding site?

Step 1: Antigen-binding sites are formed by variable heavy- and light-chain domains within Fab.

Step 2: Fc supplies class-dependent receptor, transport and complement-related interactions.

Step 3: Removing Fc can preserve binding while changing recruitment of downstream effectors.

Answer: No. Preserved Fab-mediated binding is compatible with loss of Fc-dependent functions.

Check: Binding, avidity and biological effector recruitment are distinct properties.

Worked problem 3.7: Class switching is not affinity maturation

Question: Related antibody-producing cells change from IgM to IgG while retaining the original rearranged variable-region sequence in the simplified comparison. What changed?

Step 1: The class label depends on heavy-chain constant-region use.

Step 2: A retained variable sequence preserves the underlying binding specificity in this model.

Step 3: Affinity maturation instead concerns variation and selection affecting antigen-binding quality.

Answer: Class switching changed the heavy-chain constant region; it does not itself demonstrate improved affinity.

Check: A later response can involve both processes, but they must be explained separately.

Worked problem 3.8: Interpreting two mucosal and neonatal observations

Question: Which common antibody forms best fit placental transfer and a protective secretory antibody complex in milk?

Step 1: IgG is the principal class transported across the placenta.

Step 2: Secretory IgA is an important antibody in milk and at mucosal surfaces.

Step 3: Secretory IgA includes components distinct from the Fc transport mechanism used for placental IgG.

Answer: Placental transfer: IgG. Milk-associated secretory protection: commonly secretory IgA.

Check: Passive transfer does not by itself create the infant’s own antigen-specific memory population.

Worked problem 3.9: A monoclonal reagent cross-reacts

Question: A clone-defined antibody binds its intended epitope but also binds a structurally similar determinant on another molecule. Is the preparation necessarily polyclonal?

Step 1: Monoclonal describes a defined clone or antibody sequence and shared intended specificity.

Step 2: Related molecular features can still support cross-reactivity.

Step 3: A mixture of multiple antibody-producing clones would be a different question about preparation origin.

Answer: No. A monoclonal antibody can cross-react.

Check: One defined specificity is not a guarantee of absolute recognition of only one uniquely named molecule.

Worked problem 3.10: Selection, screening and cloning are different

Question: A surviving hybridoma population has been obtained in a suitable selection framework. Has the desired monoclonal reagent already been demonstrated?

Step 1: Survival selection addresses the biological properties needed to retain suitable hybrids.

Step 2: Screening is needed to identify the required antibody binding and function.

Step 3: Cloning and validation establish a defined producer and assess performance in the intended application.

Answer: No. Survival selection alone does not establish desired specificity or monoclonality.

Check: A positive binding result on one sample format does not prove reliable performance on every sample type.

Quick Revision: Answers with Reasons

What separates innate from adaptive recognition?

Innate systems use germline-encoded recognition frameworks; adaptive B/T receptors form diverse clone-specific repertoires through gene rearrangement.

Does humoral immunity mean that no cells are involved?

No. B-lineage cells produce antibodies, and cellular effectors can be recruited by antibody-bound targets.

Are NK cells cytotoxic T cells?

No. They are innate lymphocytes with a different recognition framework, despite overlapping target-killing functions.

Can a blood-film lymphocyte be identified as B or T by shape alone?

Not reliably. Suitable markers or functional information are needed for that distinction.

Which organs are primary in the human teaching model?

Bone marrow and thymus; further peripheral maturation and other immune functions add useful qualifications.

What is the main node-versus-spleen distinction?

Nodes survey tissue-derived lymph; the spleen surveys blood-borne material.

Does mature mean antigen-activated?

No. A mature naïve cell has a functional receptor system but has not completed the relevant activating encounter.

What does positive thymic selection preserve?

Useful interaction with self-MHC in the conventional T-cell model, rather than unrestricted strong self-reactivity.

Is every antigen a strong immunogen?

No. Specific recognition and the capacity to elicit an immune response are different properties.

Which side has the epitope and which has the paratope?

The antigen carries the epitope; the antibody provides the complementary paratope.

Why can denaturation reduce binding?

A fold-dependent conformational epitope can be disrupted even when some linear sequence determinants remain.

Does an adjuvant have to be the specifically targeted antigen?

No. It can enhance the context of response without being the principal intended antigen.

What defines an antibody class?

The heavy-chain constant-region class, rather than the identity of the target antigen.

Is all IgM pentameric?

No. Membrane IgM is monomeric; the familiar secreted form is predominantly pentameric.

Are J chain and secretory component the same?

No. They have different molecular origins and roles in the secretory antibody complex.

Can low serum abundance imply unimportance?

No. IgE, for example, has important receptor-associated functions despite a low circulating concentration.

Does class switching necessarily improve affinity?

No. Switching changes class-dependent constant-region functions; affinity maturation concerns binding variants and selection.

Does polyclonal mean nonspecific?

No. A mixture can contain several specifically binding antibody populations.

Why screen hybridomas after selection?

Survival does not identify which hybrid produces the required antibody behaviour.

Does a monoclonal antibody always work in every assay?

No. Epitope accessibility, sample preparation, cross-reactivity and stability affect performance.

Quick Reference: Mechanisms and Relations

Distinction Core answer
Innate vs adaptive Pattern-based available defences versus diverse B/T clone-specific recognition and conventional memory
Humoral vs cellular Antibody-centred adaptive effectors versus T-cell-centred functions; cooperation is extensive
Primary vs secondary organ Repertoire development/selection versus organised antigen encounter
B-cell site Early marrow development; important peripheral maturation steps
T-cell site Marrow-derived precursors; thymic maturation
Antigen vs immunogen Recognised structure versus capacity to elicit a response
Epitope vs paratope Determinant on antigen versus complementary antibody binding region
Hapten / carrier / adjuvant Recognised small determinant / linked support / response-enhancing context
Monomeric antibody 2 heavy + 2 light chains; normally 2 antigen-binding sites
IgG / IgM / IgA Common serum/tissue and placental role / early multivalent secretion / mucosal secretory emphasis
IgD / IgE Common naïve BCR class / mast-cell-basophil and selected parasite-associated roles
Affinity vs avidity Individual-site interaction versus combined multivalent binding strength
Switching vs affinity maturation Constant-region class change versus binding-variant generation and selection
Monoclonal vs polyclonal Defined clone/sequence versus multiple contributing clones
Hybridoma checks Select survivors → screen function → clone → validate application
Exclusive Student Alerts

Join AKTU VIP Telegram & WhatsApp Group

Get immediate exam updates, syllabus changes, quantum PDFs, and viva questions.

Have Questions or Want to Discuss?

Join the community conversation or ask your queries in the comments.

View Comments & Discussion →
Home Notes Syllabus PYQs Quantum